Welcome To The Covalon Technologies Ltd HUB On AGORACOM
Advanced Medical Biosystems
Message: New Board Member
| January 12, 2009 |
| Covalon Welcomes New Board Member |
| MISSISSAUGA, ONTARIO--(Marketwire - Jan. 12, 2009) - Covalon Technologies Ltd. (the "Corporation" or "Covalon") (TSX VENTURE:COV) announces today that Mr. David McFaul has joined its Board of Directors. Mr. McFaul is currently Senior Vice-President of International at Boston Scientific Corporation, a world leader in cardiovascular medical products. He has worked at Boston Scientific since 1995 and held numerous leadership positions in various international markets. Brad Williams, Chairman of the Board, commented: "David McFaul is a results oriented executive with extensive experience in sales, marketing, and product development with major medical device companies who are leaders in their field. I worked with David for seven years when I was the head of Stryker Corporation's Canadian Division, and he was instrumental in helping us build a world class team that led the field in the markets in which we competed. His experience in the medical device industry and his proven track record of success positions him well to help Covalon as it enters its next phase of growth." Dr. Frank DiCosmo, President & CEO, said: "David adds valuable expertise to Covalon's Board. Prior to his current role at Boston Scientific Corporation, he served as Regional President of Asia-Pacific & Japan operations. David was also Vice President of Sales, Inter-Continental, responsible for overall sales execution for the business. The role included training and developing more than 400 sales representatives and 85 sales managers in 35 countries. David brings tremendous experience to Covalon, having been involved in high-performance sales management programs as well as clinical training programs. David has also served as Vice President and General Manager in Latin America, Canada and South Africa where he increased revenue by almost 50%. He was also General Manager, Canada and South Africa, Country Manager of Canada and National Sales Manager, Canada. I first met David almost 10 years ago, and I am very pleased to now welcome David to Covalon's Board of Directors." Covalon Technologies Ltd. is a company with advanced medical products that has developed and patented advanced therapeutic biomaterials for wound care and surgical applications and coatings. Polymer chemistry and surface coating technology have been combined to create a range of time-release drug delivery platforms that are applied to many medical devices to treat many critical conditions. A variety of applications for these technologies have been identified and specific products have been developed. The products offer features and benefits providing solutions to many of the problems caused by current devices and their material properties which are used by most medical device manufacturers and suppliers. The problems include infection, poor biocompatibility, and microbial attachment. |
Loading...
Loading...
New Message
Please
login
to post a reply